Article citationsMore>>

R. E. Ferner, J. F. Golding, M. Smith, E. Calonje, W. Jan, V. Sanjayanathan and M. O’Doherty, “[18F]2-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography (FDG PET) as a Diagnostic Tool for Neurofibromatosis 1 (NF1) Associated Malignant Peripheral Nerve Sheath Tumours (MPNSTs): A Long-Term Clinical Study,” Annals of Oncology, Vol. 19, No. 2, 2008, pp. 390-394. doi:10.1093/annonc/mdm450

has been cited by the following article:

• TITLE: Malignant Triton Tumor in the Abdominal Wall: A Case Report

  AUTHORS: Yoshiyuki Kitamura, Koichiro Abe, Shingo Baba, Takuro Isoda, Yasuhiro Maruoka, Yoshio Matsuo, Yuichiro Kubo, Akio Sakamoto, Hiroshi Nishimura, Masayuki Sasaki, Hiroshi Honda

  KEYWORDS: Malignant Triton Tumor (MTT); Malignant Peripheral Nerve Sheath Tumor (MPNST); 2-[F-18]-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography/Computed Tomography (FDG-PET/CT)

  JOURNAL NAME: Advances in Molecular Imaging, Vol.3 No.2, April 12, 2013

  ABSTRACT: Malignant triton tumor (MTT) is a rare variant of malignant peripheral nerve sheath tumor (MPNST) with rhabdomyosarcomatous differentiation. We report the case of a 54-year-old male without a history of neurofibromatosis type 1 (NF1) who had a growing abdominal wall tumor diagnosed as MTT. Computed tomography (CT), magnetic resonance imaging (MRI) and 2-[F-18]-fluoro-2-deoxy-D-glucose positron emission tomography/CT (FDG-PET/CT) were performed. The MRI and FDG-PET/CT indicated that the lateral component of the tumor was composed of many proliferative cells, corresponding to the histopathological finding of a cellular proliferation of spindle-shaped cells. In light of this case and previous reports, it is apparent that FDG-PET/CT is a helpful tool for distinguishing MTT from benign peripheral nerve sheath tumor.